Extrapulmonary effects of inhaled nitric oxide: Role of reversible S-nitrosylation of erythrocytic hemoglobin

Proceedings of the American Thoracic Society

Volumn 3, Issue 2, 2006, Pages 153-160

  McMahon, Timothy J ^a   Doctor, Allan ^b  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

^b NONE

Author keywords

Hemoglobin; Nitric oxide; Red blood cell; S nitrosohemoglobin; S nitrosothiol

Indexed keywords

CYSTEINE; GUANYLATE CYCLASE; HEMOGLOBIN; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; S NITROSOTHIOL;

BLOOD FLOW; CONFERENCE PAPER; DRUG ACTIVITY; DRUG EFFECT; ERYTHROCYTE; HUMAN; ISCHEMIA; NONHUMAN; OXYGEN SATURATION; PARACRINE SIGNALING; PULMONARY HYPERTENSION; REPERFUSION INJURY; VASCULAR RESISTANCE; VASODILATATION;

ADMINISTRATION, INHALATION; ANIMALS; BLOOD CIRCULATION; ERYTHROCYTES; HEMOGLOBINS; HUMANS; NITRIC OXIDE; VASODILATION; VASODILATOR AGENTS;

EID: 33645518594     PISSN: 15463222     EISSN: 15463222     Source Type: Journal    
DOI: 10.1513/pats.200507-066BG     Document Type: Conference Paper

References (102)

1. Frostell C, Fratacci MD, Wain JC, Jones R, Zapol WM. Inhaled nitric oxide: a selective pulmonary vasodilator reversing hypoxic pulmonary vasoconstriction. Circulation 1991;83:2038-2047.
2. Pepke-Zaba J, Higenbottam TW, Dinh-Xuan AT, Stone D, Wallwork J. Inhaled nitric oxide as a cause of selective pulmonary vasodilatation in pulmonary hypertension. Lancet 1991;338:1173-1174.
3. Jia L, Bonaventura C, Bonaventura J, Stamler JS. S-nitrosohaemoglobin: a dynamic activity of blood involved in vascular control. Nature 1996;380:221-226.
4. Gow AJ, Stamler JS. Reactions between nitric oxide and haemoglobin under physiological conditions. Nature 1998;391:169-173.
5. Gow AJ, Luchsinger BP, Pawloski JR, Singel DJ, Stamler JS. The oxyhemoglobin reaction of nitric oxide. Proc Natl Acad Sci USA 1999;96:9027-9032.
6. Singel DJ, Stamler JS. Chemical physiology of blood flow regulation by red blood cells. Annu Rev Physiol 2005;67:99-145.
7. McMahon TJ, Moon RE, Luchsinger BP, Carraway MS, Stone AE, Stolp BW, Gow AJ, Pawloski JR, Watke P, Singel DJ, et al. Nitric oxide in the human respiratory cycle. Nat Med 2002;8:711-717.
8. Stamler JS, Jia L, Eu JP, McMahon TJ, Demchenko IT, Bonaventura J, Gernert K, Piantadosi CA. Blood flow regulation by S-nitrosohemoglobin in the physiological oxygen gradient. Science 1997;276:2034-2037.
9. Gorczynski RJ, Duling BR. Role of oxygen in arteriolar functional vasodilation in hamster striated muscle. Am J Physiol 1978;235:H505-H515.
10. Gonzalez-Alonso J, Richardson RS, Saltin B. Exercising skeletal muscle blood flow in humans responds to reduction in arterial oxyhaemoglobin, but not to altered free oxygen. J Physiol 2001;530:331-341.
11. James PE, Lang D, Tufnell-Barret T, Milsom AB, Frenneaux MP. Vasorelaxation by red blood cells and impairment in diabetes: reduced nitric oxide and oxygen delivery by glycated hemoglobin. Circ Res 2004;94:976-983.
12. 2 gradients. Proc Natl Acad Sci USA 2005;102:5709-5714.
13. Datta B, Tufnell-Barrett T, Bleasdale RA, Jones CJ, Beeton I, Paul V, Frenneaux M, James P. Red blood cell nitric oxide as an endocrine vasoregulator: a potential role in congestive heart failure. Circulation 2004;109:1339-1342.
14. Funai EF, Davidson A, Seligman SP, Finlay TH. S-Nitrosohemoglobin in the fetal circulation may represent a cycle for blood pressure regulation. Biochem Biophys Res Commun 1997;239:875-877.
15. Cannon RO III, Schechter AN, Panza JA, Ognibene FP, Pease-Fye ME, Waclawiw MA, Shelhamer JH, Gladwin MT. Effects of inhaled nitric oxide on regional blood flow are consistent with intravascular nitric oxide delivery. J Clin Invest 2001;108:279-287.
16. Zuzak KJ,Gladwin MT, Cannon RO III, Levin IW. Imaging hemoglobin oxygen saturation in sickle cell disease patients using noninvasive visible reflectance hyperspectral techniques: effects of nitric oxide. Am J Physiol Heart Circ Physiol 2003;285:H1183-H1189.
17. Zuzak KJ, Schaeberle MD, Gladwin MT, Cannon RO III, Levin IW. Noninvasive determination of spatially resolved and time-resolved tissue perfusion in humans during nitric oxide inhibition and inhalation by use of a visible-reflectance hyperspectral imaging technique. Circulation 2001;104:2905-2910.
18. Gladwin MT, Schechter AN, Ognibene FP, Coles WA, Reiter CD, Schenke WH, Csako G, Waclawiw MA, Panza JA, Cannon RO III. Divergent nitric oxide bioavailability in men and women with sickle cell disease. Circulation 2003;107:271-278.
19. Rogers SC, Khalatbari A, Gapper PW, Frenneaux MP, James PE. Detection of human haemoglobin-bound nitric oxide. J Biol Chem 2005;280:26720-26728.
20. Luchsinger BP, Rich EN, Yan Y, Williams EM, Stamler JS, Singel DJ. Assessments of the chemistry and vasodilatory activity of nitrite with hemoglobin under physiologically relevant conditions. J Inorg Biochem 2005;99:912-921.
21. Cosby K, Partovi KS, Crawford JH, Patel RP, Reiter CD, Martyr S, Yang BK, Waclawiw MA, Zalos G, Xu X, et al. Nitrite reduction to nitric oxide by deoxyhemoglobin vasodilates the human circulation. Nat Med 2003;9:1498-1505.
22. Huang Z, Shiva S, Kim-Shapiro DB, Patel RP, Ringwood LA, Irby CE, Huang KT, Ho C, Hogg N, Schechter AN, Gladwin MT. Enzymatic function of hemoglobin as a nitrite reductase that produces NO under allosteric control. J Clin Invest 2005;115:2099-2107.
23. Jeffers A, Xu X, Huang KT, Cho M, Hogg N, Patel RP, Kim-Shapiro DB. Hemoglobin mediated nitrite activation of soluble guanylyl cyclase. Comp Biochem Physiol AMol Integr Physiol 2005;142:130-135.
24. Luchsinger BP, Rich EN, Gow AJ, Williams EM, Stamler JS, Singel DJ. Routes to S-nitroso-hemoglobin formation with heme redox and preferential reactivity in the β subunits. Proc Natl Acad Sci USA 2003;100:461-466.
25. Rassaf T, Feelisch M, Kelm M. Circulating NO pool: assessment of nitrite and nitroso species in blood and tissues. Free Radic Biol Med 2004;36:413-422.
26. Rassaf T, Kleinbongard P, Preik M, Dejam A, Gharini P, Lauer T, Erckenbrecht J, Duschin A, Schulz R, Heusch G, et al. Plasma nitrosothiols contribute to the systemic vasodilator effects of intravenously applied NO: experimental and clinical study on the fate of NO in human blood. Circ Res 2002;91:470-477.
27. Rassaf T, Preik M, Kleinbongard P, Lauer T, Heiss C, Strauer BE, Feelisch M, Kelm M. Evidence for in vivo transport of bioactive nitric oxide in human plasma. J Clin Invest 2002;109:1241-1248.
28. Stamler JS. S-nitrosothiols in the blood: roles, amounts, and methods of analysis. Circ Res 2004;94:414-417.
29. Frehm EJ, Bonaventura J, Gow AJ. S-nitrosohemoglobin: an allosteric mediator of NO group function in mammalian vasculature. Free Radic Biol Med 2004;37:442-453.
30. Milsom AB, Jones CJ, Goodfellow J, Frenneaux MP, Peters JR, James PE. Abnormal metabolic fate of nitric oxide in type I diabetes mellitus. Diabetologia 2002;45:1515-1522.
31. Pawloski JR, Hess DT, Stamler JS. Impaired vasodilation by red blood cells in sickle cell disease. Proc Natl Acad Sci USA 2005;102:2531-2536.
32. Strand OA, Leone A, Giercksky KE, Kirkeboen KA. Nitric oxide indices in human septic shock. Crit Care Med 2000;28:2779-2785.
33. Titheradge MA. Nitric oxide in septic shock. Biochem Biophys Acta 1999;1411:437-455.
34. Liu L, Yan Y, Zeng M, Zhang J, Hanes MA, Ahearn G, McMahon TJ, Dickfeld T, Marshall HE, Que LG, et al. Essential roles of S-nitrosothiols in vascular homeostasis and endotoxic shock. Cell 2004;116:628.
35. Jourd'heuil D, Gray L, Grisham MB. S-nitrosothiol formation in blood of lipopolysaccharide-treated rats. Biochem Biophys Res Commun 2000;273:22-26.
36. Ottesen LH, Harry D, Frost M, Davies S, Khan K, Halliwell B, Moore K. Increased formation of S-nitrothiols and nitrotyrosine in cirrhotic rats during endotoxemia. Free Radic Biol Med 2001;31:790-798.
37. Mamone G, Sannolo N, Malorni A, Ferranti P. In vitro formation of S-nitrosohemoglobin in red cells by inducible nitric oxide synthase. FEBS Lett 1999;462:241-245.
38. Crawford JH, Chacko BK, Pruitt HM, Piknova B, Hogg N, Patel RP. Transduction of NO-bioactivity by the red blood cell in sepsis: novel mechanisms of vasodilation during acute inflammatory disease. Blood 2004;104:1375-1382.
39. Kosaka H, Watanabe M, Yoshihara H, Harada N, Shiga T. Detection of nitric oxide production in lipopolysaccharide-treated rats by ESR using carbon monoxide hemoglobin. Biochem Biophys Res Commun 1992;184:1119-1124.
40. Ichinose F, Roberts JD Jr, Zapol WM. Inhaled nitric oxide: a selective pulmonary vasodilator: current uses and therapeutic potential. Circulation 2004;109:3106-3111.
41. Lipton AJ, Johnson MA, Macdonald T, Lieberman MW, Gozal D, Gaston B. S-nitrosothiols signal the ventilatory response to hypoxia. Nature 2001;413:171-174.
42. Head CA, Brugnara C, Martinez-Ruiz R, Kacmarek RM, Bridges KR, Kuter D, Bloch KD, Zapol WM. Low concentrations of nitric oxide increase oxygen affinity of sickle erythrocytes in vitro and in vivo. J Clin Invest 1997;100:1193-1198.
43. Gladwin MT, Schechter AN, Shelhamer JH, Pannell LK, Conway DA, Hrinczenko BW, Nichols JS, Pease-Fye ME, Noguchi CT, Rodgers GP, et al. Inhaled nitric oxide augments nitric oxide transport on sickle cell hemoglobin without affecting oxygen affinity. J Clin Invest 1999;104:937-945.
44. Martinez-Ruiz R, Montero-Huerta P, Hromi J, Head CA. Inhaled nitric oxide improves survival rates during hypoxia in a sickle cell (SAD) mouse model. Anesthesiology 2001;94:1113-1118.
45. de Franceschi L, Baron A, Scarpa A, Adrie C, Janin A, Barbi S, Kister J, Rouyer-Fessard P, Corrocher R, Leboulch P, et al. Inhaled nitric oxide protects transgenic SAD mice from sickle cell disease-specific lung injury induced by hypoxia/reoxygenation. Blood 2003;102:1087-1096.
46. Atz AM, Wessel DL. Inhaled nitric oxide in sickle cell disease with acute chest syndrome. Anesthesiology 1997;87:988-990.
47. Sullivan KJ, Goodwin SR, Evangelist J, Moore RD, Mehta P. Nitric oxide successfully used to treat acute chest syndrome of sickle cell disease in a young adolescent. Crit Care Med 1999;27:2563-2568.
48. Weiner DL, Hibberd PL, Betit P, Cooper AB, Botelho CA, Brugnara C. Preliminary assessment of inhaled nitric oxide for acute vaso-occlusive crisis in pediatric patients with sickle cell disease. JAMA 2003;289:1136-1142.
49. McMahon TJ, Stone AE, Bonaventura J, Singel DJ, Stamler JS. Functional coupling of oxygen-binding and vasoactivity in S-nitrosohemoglobin. J Biol Chem 2000;275:16738-16745.
50. Wolzt M, MacAllister RJ, Davis D, Feelisch M, Moncada S, Vallance P, Hobbs AJ. Biochemical characterization of S-nitrosohemoglobin: mechanisms underlying synthesis, no release, and biological activity. J Biol Chem 1999;274:28983-28990.
51. Stuart MJ, Setty BN. Sickle cell acute chest syndrome: pathogenesis and rationale for treatment. Blood 1999;94:1555-1560.
52. Foster MW, McMahon TJ, Stamler JS. S-nitrosylation in health and disease. Trends Mol Med 2003;9:160-168.
53. Rother RP, Bell L, Hillmen P, Gladwin MT. The clinical sequelae of intravascular hemolysis and extracellular plasma hemoglobin: a novel mechanism of human disease. JAMA 2005;293:1653-1662.
54. Fox-Robichaud A, Payne D, Hasan SU, Ostrovsky L, Fairhead T, Reinhardt P, Kubes P. Inhaled NO as a viable antiadhesive therapy for ischemia/reperfusion injury of distal microvascular beds. J Clin Invest 1998;101:2497-2505.
55. Adrie C, Bloch KD, Moreno PR, Hurford WE, Guerrero JL, Holt R, Zapol WM, Gold HK, Semigran MJ. Inhaled nitric oxide increases coronary artery patency after thrombolysis. Circulation 1996;94:1919-1926.
56. Fox-Robichaud A, Payne D, Kubes P. Inhaled NO reaches distal vasculatures to inhibit endothelium- but not leukocyte-dependent cell adhesion. Am J Physiol 1999;277:L1224-L1231.
57. Guery B, Neviere R, Viget N, Foucher C, Fialdes P, Wattel F, Beaucaire G. Inhaled NO preadministration modulates local and remote ischemia-reperfusion organ injury in a rat model. J Appl Physiol 1999;87:47-53.
58. Hataishi R, Morgan JG, Rodrigues ACT, Ichinose F, Zapol WM, Picard MH, Bloch KD, Scherrer-Crosbie M. Inhaled nitric oxide limits murine ischemia-reperfusion injury. Circulation 2004;110:III-50.
59. Neviere R, Mordon S, Marechal X, Buys B, Guery B, Mathieu D, Wattel F, Chopin C. Inhaled nitric oxide modulates leukocyte kinetics in the mesenteric venules of endotoxemic rats. Crit Care Med 2000;28:1072-1076.
60. Waisman D, Brod V, Dickstein R, Abramovich A, Rotschild A, Bitterman H. Effects of inhaled nitric oxide on lung injury after intestinal ischemia-reperfusion in rats. Shock 2005;23:150-155.
61. Ng ES, Jourd'heuil D, McCord JM, Hernandez D, Yasui M, Knight D, Kubes P. Enhanced S-nitroso-albumin formation from inhaled NO during ischemia/reperfusion. Circ Res 2004;94:559-565.
62. Zheng S, Zhang WY, Zhu LW, Lin K, Sun B. Surfactant and inhaled nitric oxide in rats alleviate acute lung injury induced by intestinal ischemia and reperfusion. J Pediatr Surg 2001;36:980-984.
63. Moya MP, Gow AJ, McMahon TJ, Toone EJ, Cheifetz IM, Goldberg RN, Stamler JS. S-nitrosothiol repletion by an inhaled gas regulates pulmonary function. Proc Natl Acad Sci USA 2001;98:5792-5797.
64. Moya MP, Gow AJ, Califf RM, Goldberg RN, Stamler JS. Inhaled ethyl nitrite gas for persistent pulmonary hypertension of the newborn. Lancet 2002;360:141-143.
65. Lane P, Gross S. Hemoglobin as a chariot for NO bioactivity. Nat Med 2002;8:657-658.
66. Kuebler WM, Kisch-Wedel H, Kemming GI, Meisner F, Bruhn S, Koehler C, Flondor M, Messmer K, Zwissler B. Inhaled nitric oxide induces cerebrovascular effects in anesthetized pigs. Neurosci Lett 2003;348:85-88.
67. El-Kebir D, Wang T, Yang F, Gaauvin D, Blaise G. Can inhaled nitric oxide be effectively delivered to the pig's brain? Can J Anaesth 2002;49:A100.
68. Moenkhoff M, Schmitt B, Wohlrab G, Waldvogel K, Fanconi S, Baenziger O. Electroencephalogram changes during inhalation with nitric oxide in the pediatric intensive care patient: a preliminary report. Crit Care Med 1998;26:1887-1892.
69. Mestan KK, Marks JD, Hecox K, Huo D, Schreiber MD. Neurodevelopmental outcomes of premature infants treated with inhaled nitric oxide. N Engl J Med 2005;353:23-32.
70. Barrington KJ, Etches PC, Schulz R, Talbot JA, Graham AJ, Pearson RJ, Cheung PY. The hemodynamic effects of inhaled nitric oxide and endogenous nitric oxide synthesis blockade in newborn piglets during infusion of heat-killed group B streptococci. Crit Care Med 2000;28:800-808.
71. Ishihara S, Ward JA, Tasaki O, Pruitt BA Jr, Goodwin CW Jr, Mozingo DW, Ciof. WG Jr. Inhaled nitric oxide prevents left ventricular impairment during endotoxemia. J Appl Physiol 1998;85:2018-2024.
72. Pedoto A, Tassiopoulos AK, Oler A, McGraw DJ, Hoffmann SP, Camporesi EM, Hakim TS. Treatment of septic shock in rats with nitric oxide synthase inhibitors and inhaled nitric oxide. Crit Care Med 1998;26:2021-2028.
73. Neviere R, Guery B, Mordon S, Zerimech F, Charre S, Wattel F, Chopin C. Inhaled NO reduces leukocyte-endothelial cell interactions and myocardial dysfunction in endotoxemic rats. Am J Physiol Heart Circ Physiol 2000;278:H1783-H1790.
74. Schmidt U, Han RO, DiSalvo TG, Guerrero JL, Gold HK, Zapol WM, Bloch KD, Semigran MJ. Cessation of platelet-mediated cyclic canine coronary occlusion after thrombolysis by combining nitric oxide inhalation with phosphodiesterase-5 inhibition. J Am Coll Cardiol 2001;37:1981-1988.
75. Gianetti J, Del Sarto P, Bevilacqua S, Vassalle C, De Filippis R, Kacila M, Farneti PA, Clerico A, Glauber M, Biagini A. Supplemental nitric oxide and its effect on myocardial injury and function in patients undergoing cardiac surgery with extracorporeal circulation. J Thorac Cardiovasc Surg 2004;127:44-50.
76. Charan NB, Johnson SR, Lakshminarayan S, Thompson WH, Carvalho P. Nitric oxide and β-adrenergic agonist-induced bronchial arterial vasodilation. J Appl Physiol 1997;82:686-692.
77. Lecour S, Clermont G, du Toit E, Gilson L, Maupoil V, Lowe S, Dupuis P, Girard C, Rochette L. Evidence for the extrapulmonary localization of inhaled nitric oxide. Heart Dis 2003;5:372-377.
78. 13N]nitric oxide: a positron emission tomography (PET) study. Nucl Med Biol 1996;23:773-777.
79. Preiser JC, De Backer D, Debelle F, Vray B, Vincent JL. The metabolic fate of long-term inhaled nitric oxide. J Crit Care 1998;13:97-103.
80. Takahashi Y, Kobayashi H, Tanaka N, Sato T, Takizawa N, Tomita T. Nitrosyl hemoglobin in blood of normoxic and hypoxic sheep during nitric oxide inhalation. Am J Physiol 1998;274:H349-H357.
81. Troncy E, Francoeur M, Salazkin I, Yang F, Charbonneau M, Leclerc G, Vinay P, Blaise G. Extra-pulmonary effects of inhaled nitric oxide in swine with and without phenylephrine. Br J Anaesth 1997;79:631-640.
82. Wraight WM, Young JD. Renal effects of inhaled nitric oxide in humans. Br J Anaesth 2001;86:267-269.
83. Werner J, Rivera J, Fernandez-del Castillo C, Lewandrowski K, Adrie C, Rattner DW, Warshaw AL. Differing roles of nitric oxide in the pathogenesis of acute edematous versus necrotizing pancreatitis. Surgery 1997;121:23-30.
84. Gatecel C, Mebazaa A, Kong R, Guinard N, Kermarrec N, Mateo J, Payen D. Inhaled nitric oxide improves hepatic tissue oxygenation in right ventricular failure: value of hepatic venous oxygen saturation monitoring. Anesthesiology 1995;82:588-590.
85. Kielbasa WB, Fung HL. Systemic biochemical effects of inhaled NO in rats: increased expressions of NOS III, nitrotyrosine-, and phosphotyrosine- immunoreactive proteins in liver and kidney tissues. Nitric Oxide 2001;5:587-594.
86. Beghetti M, Sparling C, Cox PN, Stephens D, Adatia I. Inhaled NO inhibits platelet aggregation and elevates plasma but not intraplatelet cGMP in healthy human volunteers. Am J Physiol Heart Circ Physiol 2003;285:H637-H642.
87. Chung A, Wildhirt SM, Wang S, Koshal A, Radomski MW. Combined administration of nitric oxide gas and iloprost during cardiopulmonary bypass reduces platelet dysfunction: a pilot clinical study. J Thorac Cardiovasc Surg 2005;129:782-790.
88. Gries A, Herr A, Kirsch S, Gunther C, Weber S, Szabo G, Holzmann A, Bottiger BW, Martin E. Inhaled nitric oxide inhibits platelet-leukocyte interactions in patients with acute respiratory distress syndrome. Crit Care Med 2003;31:1697-1704.
89. Gries A, Herr A, Motsch J, Holzmann A, Weimann J, Taut F, Erbe N, Bode C, Martin E. Randomized, placebo-controlled, blinded and cross-matched study on the antiplatelet effect of inhaled nitric oxide in healthy volunteers. Thromb Haemost 2000;83:309-315.
90. Gessler P, Nebe T, Birle A, Mueller W, Kachel W. A new side effect of inhaled nitric oxide in neonates and infants with pulmonary hypertension: functional impairment of the neutrophil respiratory burst. Intensive Care Med 1996;22:252-258.
91. Malmros C, Blomquist S, Dahm P, Martensson L, Thorne J. Nitric oxide inhalation decreases pulmonary platelet and neutrophil sequestration during extracorporeal circulation in the pig. Crit Care Med 1996;24:845-849.
92. Busse R, Fleming I. Pulsatile stretch and shear stress: physical stimuli determining the production of endothelium-derived relaxing factors. J Vasc Res 1998;35:73-84.
93. Davies PF. Flow-mediated endothelial mechanotransduction. Physiol Rev 1995;75:519-560.
94. Fagan KA, Tyler RC, Sato K, Fouty BW, Morris KG Jr, Huang PL, McMurtry IF, Rodman DM. Relative contributions of endothelial, inducible, and neuronal NOS to tone in the murine pulmonary circulation. Am J Physiol 1999;277:L472-L478.
95. Deem S, Swenson ER,Alberts MK, Hedges RG, Bishop MJ. Red-bloodcell augmentation of hypoxic pulmonary vasoconstriction: hematocrit dependence and the importance of nitric oxide. Am J Respir Crit Care Med 1998;157:1181-1186.
96. Shen W, Hintze TH, Wolin MS. Nitric oxide: an important signaling mechanism between vascular endothelium and parenchymal cells in the regulation of oxygen consumption. Circulation 1995;92:3505-3512.
97. Frangos JA, Huang TY, Clark CB. Steady shear and step changes in shear stimulate endothelium via independent mechanisms: superposition of transient and sustained nitric oxide production. Biochem Biophys Res Commun 1996;224:660-665.
98. Kubes P, Suzuki M, Granger DN. Nitric oxide: an endogenous modulator of leukocyte adhesion. Proc Natl Acad Sci USA 1991;88:4651-4655.
99. Lefer AM, Lefer DJ. Nitric oxide. II. Nitric oxide protects in intestinal inflammation. Am J Physiol 1999;276:G572-G575.
100. Pawloski JR, Swaminathan RV, Stamler JS. Cell-free and erythrocytic S-nitrosohemoglobin inhibits human platelet aggregation. Circulation 1998;97:263-267.
101. Gries A, Bode C, Peter K, Herr A, Bohrer H, Motsch J, Martin E. Inhaled nitric oxide inhibits human platelet aggregation, P-selectin expression, and fibrinogen binding in vitro and in vivo. Circulation 1998;97:1481-1487.
102. Pawloski JR, Hess DT, Stamler JS. Export by red blood cells of nitric oxide bioactivity. Nature 2001;409:622-626.